Alan Musso

2023

In 2023, Alan Musso earned a total compensation of $1.9M as Chief Financial Officer at Fulcrum Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$61,700
Option Awards$1,605,754
Salary$180,682
Other$31,697
Total$1,879,833

Musso received $1.6M in option awards, accounting for 85% of the total pay in 2023.

Musso also received $61.7K in non-equity incentive plan, $180.7K in salary and $31.7K in other compensation.

Rankings

In 2023, Alan Musso's compensation ranked 567th out of 2,907 executives tracked by ExecPay. In other words, Musso earned more than 80.5% of executives.

ClassificationRankingPercentile
All
567
out of 2,907
81st
Division
Manufacturing
324
out of 1,599
80th
Major group
Chemicals And Allied Products
226
out of 901
75th
Industry group
Drugs
223
out of 864
74th
Industry
Pharmaceutical Preparations
139
out of 622
78th
Source: SEC filing on April 19, 2024.

Musso's colleagues

We found five more compensation records of executives who worked with Alan Musso at Fulcrum Therapeutics in 2023.

2023

Alex Sapir

Fulcrum Therapeutics

Chief Executive Officer

2023

Curtis Oltmans

Fulcrum Therapeutics

Chief Legal Officer

2023

Mel Hayes

Fulcrum Therapeutics

Executive Vice President, Patient Affairs

2023

Bryan Stuart

Fulcrum Therapeutics

Chief Executive Officer

2023

Robert Gould

Fulcrum Therapeutics

Chief Executive Officer

News

In-depth

You may also like